Renoprotection Provided by Dipeptidyl Peptidase-4 Inhibitors in Combination with Angiotensin Receptor Blockers in Patients with Type 2 Diabetic Nephropathy

BACKGROUND: Treatment with the dipeptidyl peptidase-4 inhibitors (DPP4i) and angiotensin receptor blockers (ARBs) in patients with type 2 diabetic nephropathy (DN) has not been well characterized. This study aimed to assess the renoprotection of this combined treatment in DN patients. METHODS: A tot...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Dan-Dan, Liu, Jing, Shi, Jing-Song, An, Yu, Ge, Yong-Chun, Zhou, Min-Lin, Jiang, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247590/
https://www.ncbi.nlm.nih.gov/pubmed/30425192
http://dx.doi.org/10.4103/0366-6999.245277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247590/
https://www.ncbi.nlm.nih.gov/pubmed/30425192
http://dx.doi.org/10.4103/0366-6999.245277

Ejemplares similares